Literature DB >> 9201301

A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells.

M Makino1, M Baba.   

Abstract

The establishment of a cryopreservation method for unstimulated fresh peripheral blood mononuclear cells (PBMC) with nearly 100% viability would greatly contribute to the conduct of various immunological experiments. The cells most sensitive to freezing and thawing procedure seem to be dendritic cells (DC) and their precursors, which are of the most potent antigen-presenting cells. The authors investigated and established a method of cryopreserving fresh PBMC from which DC were recovered and differentiated efficiently by using recombinant (r) GM-CSF and rIL-4. PBMC frozen in the presence of 12% dimethylsulfoxide and 25-30% fetal calf serum recovered DC as efficiently as freshly obtained PBMC. Established DC could also be cryopreserved in the presence of 12% DMSO with their viability maintained at more than 90%. The 12% DMSO freezing solutions were superior to both the 10% DMSO solution and the previously reported DC freezing medium (2 M or 15.4% DMSO). The DC obtained from the cryopreserved PBMC expressed HLA-DR, HLA-DQ, CD80 and CD86 antigens, and stimulated allogenic PBMC to an extent almost identical to that obtained from fresh PBMC. These findings indicate that the conditioned medium utilized here enables safe cryopreservation of DC and DC precursors in PBMC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201301     DOI: 10.1046/j.1365-3083.1997.d01-441.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  23 in total

1.  Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  M Makino; M Azuma; S I Wakamatsu; Y Suruga; S Izumo; M M Yokoyama; M Baba
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

Authors:  Chunmei Cheng; Sukumar Pal; Ilham Bettahi; Kristie L Oxford; Peter A Barry; Luis M de la Maza
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

3.  Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.

Authors:  Masahiko Makino; Yumi Maeda; Katsuya Inagaki
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

4.  Human T lymphocyte priming in vitro by haptenated autologous dendritic cells.

Authors:  T Rustemeyer; S De Ligter; B M Von Blomberg; P J Frosch; R J Scheper
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Identification of an Immunomodulating Agent from Mycobacterium leprae.

Authors:  Yumi Maeda; Tetsu Mukai; John Spencer; Masahiko Makino
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Efficient activation of human T cells of both CD4 and CD8 subsets by urease-deficient recombinant Mycobacterium bovis BCG that produced a heat shock protein 70-M. tuberculosis-derived major membrane protein II fusion protein.

Authors:  Tetsu Mukai; Yumiko Tsukamoto; Yumi Maeda; Toshiki Tamura; Masahiko Makino
Journal:  Clin Vaccine Immunol       Date:  2013-10-23

Review 8.  Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

Authors:  R Hájek; A W Butch
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

9.  The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  M Makino; S Shimokubo; S I Wakamatsu; S Izumo; M Baba
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

10.  Loss of T cell responses following long-term cryopreservation.

Authors:  Rachel E Owen; Elizabeth Sinclair; Brinda Emu; John W Heitman; Dale F Hirschkorn; C Lorrie Epling; Qi Xuan Tan; Brian Custer; Jeffery M Harris; Mark A Jacobson; Joseph M McCune; Jeffery N Martin; Frederick M Hecht; Steven G Deeks; Philip J Norris
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.